Table 1. Binding Affinities and Functional Activities at the Human Opioid Receptors and Calculated Physicochemical Properties of New Diphenethylamines 3–22 and Reference Compounds 1 and 2.
| receptor
binding (Ki, nM)a |
functional activityb |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| affinity |
selectivity |
[35S]GTPγS KOP |
physicochemical propertiesc |
||||||
| compd | KOP | MOP | DOP | MOP/KOP | DOP/KOP | EC50 or Ke (nM) | % stim | clogP | clogD7.4 |
| 1d | 0.49 ± 0.20 | 542 ± 239 | >10000 | 1106 | >20000 | 3.62 ± 1.87 | 90.0 ± 3.7 | 5.04 | 2.04 |
| 2d | 5.90 ± 3.00 | 826 ± 98 | >10000 | 140 | >1700 | 35.0 ± 5.3 | 53.4 ± 8.1 | 4.64 | 1.73 |
| 3 | 0.017 ± 0.002 | 274 ± 20 | 2268 ± 625 | 16118 | 133471 | 3.87 ± 1.44 | 82.8 ± 3.7 | 5.43 | 2.34 |
| 4 | 0.061 ± 0.027 | 537 ± 172 | 2139 ± 346 | 8803 | 35066 | 0.23 ± 0.08 | 61.9 ± 8.1 | 5.83 | 2.73 |
| 5 | 0.71 ± 0.25 | 463 ± 95 | 1862 ± 501 | 652 | 2623 | 4.65 ± 1.63 | 79.5 ± 9.8 | 5.71 | 3.16 |
| 6 | 10.3 ± 1.2 | 670 ± 174 | 3539 ± 38 | 65 | 344 | 46.1 ± 13.9 | 50.7 ± 5.0 | 4.72 | 1.96 |
| 7 | 2.69 ± 0.43 | 259 ± 86 | 2743 ± 677 | 96 | 1020 | 22.1 ± 3.1 | 74.7 ± 3.6 | 5.47 | 2.61 |
| 8 | 0.38 ± 0.09 | 230 ± 43 | 3340 ± 844 | 605 | 8789 | 4.44 ± 1.36 | 71.1 ± 5.2 | 4.75 | 1.81 |
| 9 | 4.62 ± 0.11 | 631 ± 215 | 2850 ± 720 | 137 | 617 | 20.6 ± 0.6 | 51.3 ± 7.6 | 4.35 | 1.51 |
| 10 | 19.1 ± 0.6 | 358 ± 28 | 738 ± 16 | 19 | 39 | 154 ± 62 | 37.5 ± 0.6 | 4.39 | 2.49 |
| 11 | 0.14 ± 0.04 | 167 ± 52 | 1432 ± 506 | 1193 | 10229 | 17.6 ± 7.1 | 91.1 ± 3.6 | 5.54 | 2.50 |
| 12 | 0.31 ± 0.04 | 584 ± 119 | 2775 ± 545 | 1884 | 8952 | 13.7 ± 3.5 | 80.4 ± 5.8 | 5.15 | 2.11 |
| 13 | 2.10 ± 0.26 | 211 ± 17 | 1469 ± 147 | 100 | 699 | 16.6 ± 0.7 | 65.6 ± 3.4 | 5.18 | 2.39 |
| 14 | 3.43 ± 0.75 | 16.1 ± 4.7 | 428 ± 93 | 5 | 125 | 22.2 ± 3.6 | 76.4 ± 1.1 | 4.75 | 1.77 |
| 15 | 1.85 ± 0.07 | 234 ± 112 | 1637 ± 557 | 126 | 885 | 22.2 ± 7.2 | 84.3 ± 2.7 | 5.54 | 2.46 |
| 16 | 43.5 ± 1.5 | 192 ± 17 | 1099 ± 485 | 4 | 25 | 248 ± 89 | 29.8 ± 3.4 | 4.39 | 2.44 |
| 17 | 3.56 ± 0.94 | 460 ± 127 | >10000 | 129 | >2800 | 24.3 ± 1.5e | 4.35 | 1.46 | |
| 18 | 0.072 ± 0.027 | 398 ± 57 | >10000 | 5529 | >138000 | 6.90 ± 3.35 | 66.1 ± 10.6 | 5.17 | 2.56 |
| 19 | 0.040 ± 0.006 | 851 ± 292 | >10000 | 21275 | >250000 | 2.77 ± 0.29 | 88.9 ± 4.6 | 5.97 | 3.28 |
| 20 | 0.12 ± 0.01 | 557 ± 198 | >10000 | 4642 | >83000 | 1.49 ± 0.04 | 57.5 ± 4.4 | 4.89 | 2.32 |
| 21 | 3.37 ± 1.54 | 523 ± 33 | 1312 ± 281 | 155 | 389 | 36.7 ± 14.0 | 69.1 ± 1.9 | 4.89 | 2.29 |
| 22 | 79.1 ± 12.5 | 1065 ± 263 | 2178 ± 881 | 13 | 28 | 359 ± 116 | 91.9 ± 4.7 | 5.32 | 2.26 |
Determined in competition binding assays using CHO cell membranes stably expressing human opioid receptors (CHO-hKOP, CHO-hMOP, or CHO-hDOP cells).
Determined in the [35S]GTPγS binding assay using CHO-hKOP cell membranes. Percentage stimulation (% stim) relative to the KOP full agonist U69,593.
Calculated log P (clogP) and calculated log D at pH 7.4 (clogD7.4) using MarvinSketch 17.10 (ChemAxon).
Data from ref (9a).
Antagonist Ke value at the KOP receptor against U69,593 determined in the [35S]GTPγS binding assay. Values are means ± SEM of at least three independent experiments.